论文部分内容阅读
冠心病的介入治疗已广泛应用于临床。药物洗脱支架作为新技术,被多项临床研究证实其安全性和降低再狭窄率的有效性。药物洗脱支架兴起后短短的几年内,在冠心病的介入治疗中发挥了巨大作用。随着其在临床应用的普及和应用范围的推广,研究发现支架血栓尤其是晚期及极晚期支架有增加的趋势。但是就支架血栓问题,各研究报道不一,临床意义尚不明确,现根据最新研究文献作一综述。
Coronary heart disease intervention has been widely used in clinical. As a new technology, drug-eluting stents have been validated by several clinical studies for their safety and effectiveness in reducing the rate of restenosis. Within a few short years after the drug-eluting stent has been established, it has played a huge role in the interventional treatment of coronary heart disease. As its popularity in the clinical application and the promotion of the scope of application, the study found that stent thrombosis, especially late and very late stent has an increasing trend. However, the issue of stent thrombosis, various studies have reported different clinical significance is not clear, are based on the latest research literature review.